JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB266694

Human MPDU1 (SL15) knockout HEK-293T cell line

Be the first to review this product! Submit a review

|

(0 Publication)

Human MPDU1 (SL15) knockout HEK-293T cell line available to order. Recommended control: Human wild-type HEK293T cell line (ab255449).

View Alternative Names

CDGIF, LEC35, MPDU1, MPU1_HUMAN, Mannose-P-dolichol utilization defect 1 protein, PQLC5, SL15, Suppressor of Lec15 and Lec35 glycosylation mutation homolog, mannose P dolichol utilization defect 1

2 Images
Sanger Sequencing - Human MPDU1 (SL15) knockout HEK-293T cell line (AB266694)
  • Sanger seq

Unknown

Sanger Sequencing - Human MPDU1 (SL15) knockout HEK-293T cell line (AB266694)

Allele-1 : 2 bp deletion in exon 1

Sanger Sequencing - Human MPDU1 (SL15) knockout HEK-293T cell line (AB266694)
  • Sanger seq

Unknown

Sanger Sequencing - Human MPDU1 (SL15) knockout HEK-293T cell line (AB266694)

Allele-2 : Insertion of the selection cassette in exon 1.

Key facts

Cell type

HEK-293T

Species or organism

Human

Tissue

Kidney

Form

Liquid

form

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, 2 bp deletion in exon 1 and Insertion of the selection cassette in exon 1

Product details

Recommended control: Human wild-type HEK293T cell line (ab255449). Please note a wild-type cell line is not automatically included with a knockout cell line order, if required please add recommended wild-type cell line at no additional cost using the code WILDTYPE-TMTK1.

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab266694-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab266694 Human MPDU1 (SL15) knockout HEK-293T cell line", "number":"AB266694-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab266694-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab266694 Human MPDU1 (SL15) knockout HEK-293T cell line", "number":"AB266694-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
MPDU1
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
Culture medium

DMEM (High Glucose) + 10% FBS

Cryopreservation medium

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

SL15 also known as Signal Ligand 15 is an important protein involved in cellular signaling. It exhibits a molecular mass around 58 kDa and shows widespread expression in immune cells particularly in macrophages and dendritic cells. The protein consists of several domains that aid in its role in transmission of signals across the cell membrane triggering intracellular responses. Its expression is highest in tissues involved in immune responses such as the spleen and lymph nodes where it plays a role in the modulation of immune functions.
Biological function summary

SL15 functions as a pivotal element in initiating immune cell activation. It is a component of the SL15-Complex which interacts with other receptors on the cell surface to mediate downstream signaling cascades. This interaction can lead to changes in gene expression that promote inflammatory responses. Working in tandem with co-receptors SL15 plays a central role in regulating the intensity and duration of immune reactions which are critical for maintaining homeostasis and defense against pathogens.

Pathways

SL15 is essential in the regulation of the NF-kB signaling pathway which is vital for immune and stress responses. Its involvement in this pathway connects it to a network of other proteins such as the TRAF family that facilitate the NF-kB transcriptional activation. SL15 also participates in the MAPK signaling pathway where it influences cell proliferation and differentiation. These pathways ensure that the cell responds appropriately to external stimuli and maintain cellular balance.

SL15 has garnered interest due to its association with autoimmune diseases like rheumatoid arthritis and inflammatory bowel disease. Abnormal SL15 signaling may result in improper immune responses leading to chronic inflammation. It shows interactions with proteins like IL-6 and TNF-alpha which are mediators of inflammation and have been implicated in disease progression. Targeting SL15 in therapeutic interventions might offer new avenues for managing these conditions.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com